Researchers Explain Azvudine Mechanism Against COVID-19
A study details how the drug prevents SARS-CoV-2 exonuclease cleavage during viral replication.
Updated on Oct. 4, 2026 in COVID-19
Scientists have identified a precise mechanism by which the antiviral drug Azvudine inhibits SARS-CoV-2. The process involves incorporating the drug into the penultimate position of viral RNA to prevent exonuclease cleavage.
Why it matters
Understanding this molecular interaction provides critical insights for the future design of antiviral therapies. These findings help researchers develop more effective nucleotide analogs to combat viral replication.
The study confirms that Azvudine-triphosphate inhibits viral polymerases and triggers resistance to exonuclease cleavage when positioned at the penultimate RNA site. These data are drawn from a 2026 molecular analysis of viral synthesis inhibitors.
The players
SARS-CoV-2
This virus is the causative agent of the global COVID-19 pandemic and utilizes RNA-dependent RNA polymerase for replication.
Azvudine
This is a cytidine analog medication authorized for use as a COVID-19 treatment in China.
The details
Azvudine functions as a cytidine analog that the SARS-CoV-2 RNA-dependent RNA polymerase incorporates into viral RNA, effectively hindering further nucleotide synthesis. When the drug is located at the penultimate position of the RNA strand, it blocks the virus's exonuclease from performing its typical cleavage process.
Timeline
October 4, 2026: The research findings were published on nature.com.
The Big Picture
This research advances the design principles established in the ongoing development of nucleoside analog inhibitors. It provides a structural blueprint for how future treatments can be optimized to bypass viral defensive mechanisms.
This discovery refines the scientific understanding of how current COVID-19 treatments interact with the virus at a molecular level. While this does not change current prescription routines, it informs the future landscape of antiviral medication development for patients.
The takeaway
This study highlights the importance of precise molecular placement in drug design to overcome viral defenses. Researchers can use these findings to improve the potency of next-generation antiviral therapies.
Further reading
Learn more about the latest research and treatments in our COVID-19 section.
Source note: This article includes information reported by Nature.
